The University of Cambridge is a public collegiate research university in Cambridge, England. Founded in 1209 and granted a royal charter by Henry III in 1231, Cambridge is the world's third oldest ...

During the past decade, University of Cambridge; Department of Clinical Neurosciences conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cambridge; Department of Clinical Neurosciences" #1 collaborator was "Innovative Medicines Initiative" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Cambridge; Department of Clinical Neurosciences" are "Alzheimer's Dementia" (1 trials), "Mitochondrial Complex I Deficiency" (1 trials), "Mitochondrial DNA Deletion" (1 trials), "Mitochondrial DNA Depletion" (1 trials) and "Mitochondrial DNA Mutation" (1 trials). Many other conditions were trialed in "University of Cambridge; Department of Clinical Neurosciences" in a lesser frequency.

Most popular intervention types in "University of Cambridge; Department of Clinical Neurosciences" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Elamipretide" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Cambridge; Department of Clinical Neurosciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Cambridge; Department of Clinical Neurosciences". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Cambridge; Department of Clinical Neurosciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cambridge; Department of Clinical Neurosciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".